Login
← Go Back
Norris Medicines
NORRISMEDI · Pharma > Pharmaceuticals & Drugs Listing date: March 21, 2018
Stock Price vs Company Growth
1d
6.4%
1w
28.7%
1m
42.8%
3m
33.4%
6m
20.6%
1y
5.6%
5y
24.7%
all
4.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 19 6.4%
12.8
19.6
Company Overview
Sales
8.13 Cr
Growth: 28.6%
Profit after Tax
-0.28 Cr
Growth: -49.9%
Micro Cap
19 Cr
P/S: 2.3x
Industry P/S: 2.7x
Fundamentals
Sales (Cr) ₹ 8.13
Growth 28.6%
EBITDA 8.2%
P/S 2.3x
Dividend 0.0%
P/E -67.8x
Book Value ₹ -13.3
PEG Ratio -2.0x
ROE 2.1%
P/B N/A
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The business area of the company is manufacturing of Injections and Medicinal formulations.Products of company The products of the company covers wide range of modern medicinal field such as Antibiotics, Anti Inflammatory, Dermatology, Nutrition, Gastro, Anti malarial, Dental, Diabetic & Cardiac.Milestones1992: Launch of Ethical Division and conversion of company into Public Limited company.1994: WHO cGMP Certificate.1995: Major Expansions.
Investors (1)
vimal.sh...